Employing a Recombinant HLA-DR3 Expression System to Dissect Major Histocompatibility Complex II-Thyroglobulin Peptide Dynamism
Authors:
- Eric M. JacobsonEJEric M. Jacobson
- Heyi YangHYHeyi Yang
- Francesca MenconiFMFrancesca Menconi
- Rong WangRWRong Wang
- Roman OsmanRORoman Osman
- Luce SkrabanekLSLuce Skrabanek
- Cheuk Wun LiCLCheuk Wun Li
- Mohammed FadlallaMFMohammed Fadlalla
- Alisha GandhiAGAlisha Gandhi
- Vijaya ChaturvediVCVijaya Chaturvedi
- Eric P. SmithESEric P. Smith
- Sandy SchwembergerSSSandy Schwemberger
Open Access
- 1 December 2009
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 284 (49) , 34231-34243
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' diseaseHuman Molecular Genetics, 2009
- Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in miceProceedings of the National Academy of Sciences, 2008
- The HLA gene complex in thyroid autoimmunity: From epidemiology to etiologyJournal of Autoimmunity, 2008
- Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' diseaseGenes & Immunity, 2004
- MHC-Linked Susceptibility to Type 1 DiabetesAnnals of the New York Academy of Sciences, 2003
- HLA Class II peptide‐binding and autoimmunityTissue Antigens, 2002
- Gamma‐interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophagesFEBS Letters, 1995
- Microvariation creates significant functional differences in the DR3 MoleculesHuman Immunology, 1995
- HLA-DRα chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopesHuman Immunology, 1994
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992